Up-regulation of PDK4 enhances the resistance of hepatocytes and colon cancer cells to chemotherapy-induced toxicity, while down-regulation of PDK4 enhances chemotherapy-related cell damage. The gene discussed is PDK4; the disease is colonic neoplasm.